Back
Greek Organisation of Football Prognostics SA Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
54
GOFPY
Greek Organisation of Football Prognostics SA
Last Price:
$10.54
Seasonality Move:
7.35%
Buy
77
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.15
Seasonality Move:
9.28%
Buy
54
Greek Organisation of Football Prognostics SA (GOFPY)
is a Buy
Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?
-
The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $10.54. The Score for GOFPY is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
GOFPY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.31. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GOFPY Stock Price Chart
What is Greek Organisation of Football Prognostics SA's stock price today?
-
The Greek Organisation of Football Prognostics SA share price today is $10.54The current trend is relatively stagnant and GOFPY is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.31The current trend is moderately bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
GOFPY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 50.81 | Buy |
| Chaikin Money Flow: | -19284 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.97 - 10.71) | Buy |
| Bollinger Bands (100): | (10.34 - 11.7) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 17.9 | Buy |
| Relative Strength Index (14 RSI): | 84.85 | Buy |
| Chaikin Money Flow: | 566238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (179.97 - 241.41) | Buy |
| Bollinger Bands (100): | (53.79 - 174.17) | Buy |
GOFPY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.76 | Sell |
| 20-day SMA: | 10.43 | Buy |
| 50-day SMA: | 10.48 | Buy |
| 200-day SMA: | 10.89 | Sell |
| 8-day EMA: | 10.68 | Sell |
| 20-day EMA: | 10.54 | Buy |
| 50-day EMA: | 10.6 | Sell |
| 200-day EMA: | 10.57 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.16 | Buy |
| 20-day SMA: | 220.01 | Buy |
| 50-day SMA: | 157.24 | Buy |
| 200-day SMA: | 71.79 | Buy |
| 8-day EMA: | 219.83 | Buy |
| 20-day EMA: | 208.3 | Buy |
| 50-day EMA: | 169.39 | Buy |
| 200-day EMA: | 91.98 | Buy |
Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Greek Organisation of Football Prognostics SA Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||